Hospital officials say the new project is a first-of-its kind initiative for Connecticut, in today's bite-sized hospital and health industry news from Connecticut, District of Columbia, and Indiana.
- Connecticut: Yale-New Haven Hospital on Monday announced that it is building an $838 million neurosciences center on its Saint Raphael campus. The 505,000 square foot facility will have 204 patient beds. Robert Alpern, dean of Yale Medical School, said the new center, which is slated to open in 2024, will conduct research on ALS, stroke, Parkinson's Disease, and other neurological disorders (Kovner, Hartford Courant, 4/29).
- District of Columbia: On Tuesday, Providence Hospital officially closed its doors after 158 years in operation. Washington, D.C. officials said the hospital's closure will create a gap in emergency care for residents that live in the Eastern side of the District of Columbia. The hospital last year performed more than 5,500 ambulatory surgeries, and had more than 43,000 ED visits and 4,900 inpatient admissions. Ascension, which owns the hospital, said it will continue to offer primary care and outpatient behavioral health services, and patients will continue to have access to its retail pharmacy (Carrasco, NBC Washington, 4/30; Paavola, Becker's Hospital Review, 5/1).
- Indiana: Indiana Health Commissioner Kris Box on Tuesday ordered that Indiana adults do not need to obtain a prescription in order to receive the measles, mumps, and rubella vaccine. Under the new order, Indiana residents can get the vaccine at any pharmacy that carries it. Vaccines provided under the order will be billed to insurance (AP/Sacramento Bee, 4/30).
Get our ready-to-use slides on the latest neurosciences market trends
Download the slides to learn everything you'll need to know about the neuroscience market in 2019, from growth outlook and financial considerations to new care management priorities and technology innovations.